Avaí Bio, Inc.
AVAI
$0.17
-$0.02-8.81%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 90.40K | 503.30K | 364.30K | 481.10K | -54.20K |
| Depreciation & Amortization | 6.50K | 6.50K | 6.50K | 6.50K | 15.80K |
| Other Operating Expenses | -102.30K | 44.00K | 58.40K | -- | -34.90K |
| Total Operating Expenses | -14.10K | 553.70K | 453.00K | 487.60K | -73.40K |
| Operating Income | 14.10K | -553.70K | -453.00K | -487.60K | 73.40K |
| Income Before Tax | -255.20K | -553.70K | -453.00K | -487.60K | 464.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -255.20K | -553.70K | -453.00K | -487.60K | 464.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -255.20K | -553.70K | -453.00K | -487.60K | 464.10K |
| EBIT | 14.10K | -553.70K | -453.00K | -487.60K | 73.40K |
| EBITDA | 20.70K | -547.20K | -446.50K | -481.10K | 89.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 138.78M | 138.03M | 137.62M | 137.46M | 137.07M |
| Average Diluted Shares Outstanding | 138.78M | 138.03M | 137.62M | 137.46M | 137.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |